 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
December 26, 2008
ZymoGenetics
ZymoGenetics will form a Biosurgery Business Unit focused on maximizing the commercial potential of Recothrom Thrombin, topical. Stephen Zaruby will lead the new division as general manager of the unit, and will also serve as president of ZymoGenetics, effective Jan. 2. Zaruby worked at Bayer HealthCare Pharmaceuticals.